NCT02616380View on ClinicalTrials.gov

Real-World Outcome of Adalimumab on Rheumatoid Arthritis Patients in Taiwan

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 5, 2015

Primary Completion Date

November 23, 2017

Study Completion Date

November 23, 2017

Conditions
Rheumatoid Arthritis
Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
lead

AbbVie

INDUSTRY